• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, July 11, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Clostridium difficile infections have decreased 36 percent in Canadian hospitals

Bioengineer by Bioengineer
June 25, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Rates of C. difficile infections have decreased 36% in hospitals across Canada, although the virulent NAP1 strain associated with severe illness and deaths is the most common strain, according to research published in CMAJ (Canadian Medical Association Journal)

Clostridium difficile is the most common infectious cause of diarrhea in hospitalized patients in developed countries, causing severe illness and occasionally death. Seniors and people on antibiotic treatment are most vulnerable to infection. However, the NAP1 strain of C. difficile, which is most virulent and can be resistant to treatment with fluoroquinolone antibiotics, has emerged in healthy people and in the community, spreading after several epidemics in the early 2000s.

A pan-Canadian team of researchers from the Canadian Nosocomial Infection Surveillance Program looked at data from 42-53 acute care hospitals over 7 years (2009-2015) to understand patterns of NAP1 strain and effect of infection on patient outcomes. A total 20 623 cases of hospital-acquired C. difficile occurred, mostly in hospitals with more than 200 beds. Infection rates decreased 35.8% across Canada by 2015, although the number of younger patients with the disease increased.

Improvements in infection-control measures (such as improved testing, more judicious use of antibiotics, frequent handwashing, and better and more frequent cleaning of facilities) begun after outbreaks 10-15 years ago may have contributed to the decrease in infection rates.

The large study found an association between the NAP1 strain and death in patients aged 18 and older, not detected by earlier single-centre or provincial-level studies.

"Our findings suggest that, as the proportion of NAP1 strain isolates decreases in relation to all circulating strains, both the rate of health care-associated C. difficile infection and the number of severe cases can be expected to decrease relative to a peer hospital with a higher proportion of NAP1 circulating isolates," says Dr. Kevin Katz, North York General Hospital, Toronto, Ontario.

The authors recommend continued vigilance to better contain infection.

"Infection prevention and control practices, antimicrobial stewardship and environmental cleaning should continue to be strengthened at the local level, as these areas positively affect institutional rates of health care-associated C. difficile infection, regardless of circulating strain types."

###

"The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009-2015)" is published June 25, 2018.

Visual abstract: https://bit.ly/2M3mrAD

Media Contact

Kim Barnhardt
[email protected]
@CMAJ

http://www.cmaj.ca/

Share12Tweet8Share2ShareShareShare2

Related Posts

Calcineurin/NFAT Pathway Links Calcium Stress to Neurodegeneration Timing

July 11, 2026

Pycnogenol Reduces Neurobehavioral and Liver Damage from Thioacetamide Exposure

July 11, 2026

Norwegian Stakeholders Review Guidelines to Prevent Elder Abuse

July 11, 2026

Physiatrists Evolve from Team Players to Leaders in Parkinson’s Care

July 11, 2026
Please login to join discussion

POPULAR NEWS

  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15
  • KTU Researchers Explore Ultrasound’s Role in Enhancing Blood Flow Beyond Diagnostics

    53 shares
    Share 21 Tweet 13
  • 高齢者の骨粗鬆症治療の持続性比較

    51 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Calcineurin/NFAT Pathway Links Calcium Stress to Neurodegeneration Timing

Pycnogenol Reduces Neurobehavioral and Liver Damage from Thioacetamide Exposure

Norwegian Stakeholders Review Guidelines to Prevent Elder Abuse

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.